Ovarian Reserve Check (AMH)

A single-marker test measuring Anti-Mullerian Hormone (AMH) to assess ovarian reserve — the quantity of remaining eggs. An important data point for women considering future fertility, planning egg freezing, or evaluating their reproductive timeline.

Anti-Mullerian Hormone is produced by the small follicles in the ovaries and provides the most reliable blood-based estimate of remaining egg quantity. Unlike FSH and oestradiol (which fluctuate through the menstrual cycle), AMH can be measured at any point in the cycle and remains relatively stable, making it a convenient and reliable marker. AMH levels naturally decline with age as the ovarian reserve depletes, but there is significant individual variation — some women in their early 30s have AMH levels typical of women a decade older, while others maintain high levels into their late 30s. Knowing where you stand provides crucial information for family planning decisions. It is important to note that AMH measures egg quantity, not quality. A woman with lower AMH may still conceive naturally, while a woman with high AMH is not guaranteed fertility. However, low AMH does indicate that the window of opportunity may be shorter than average, making this information valuable for planning. This test is increasingly sought by women in their late 20s and early 30s who want data to inform decisions about timing of pregnancy, egg freezing, or other fertility preservation options.